Laura Brege
Direttore/Membro del Consiglio presso EDGEWISE THERAPEUTICS, INC.
Patrimonio netto: 1 M $ in data 31/05/2024
Profilo
Laura A.
Brege is currently serving as the Chairman of Council on International Educational Exchange, Inc. She is also an Independent Director at ACADIA Pharmaceuticals, Inc., Pacira Biosciences, Inc., Pacira Pharmaceuticals, Inc. (California), Ohio University Foundation, HLS Therapeutics, Inc., Edgewise Therapeutics, Inc., Mirum Pharmaceuticals, Inc., and T-Knife Therapeutics, Inc. In her former roles, Ms. Brege served as the President, Chief Executive Officer & Director of Nodality, Inc. from 2013 to 2015.
She was an Independent Director at Delcath Systems, Inc. from 2013 to 2014.
She also served as an Independent Director at Dynavax Technologies Corp.
from 2015 to 2020.
Ms. Brege was a Director at Angiotech Pharmaceuticals, Inc. from 2007 to 2011 and an Independent Director at Portola Pharmaceuticals LLC from 2015 to 2020.
She held the position of Director at Zvents, Inc. and served as an Independent Director at Aratana Therapeutics, Inc. from 2014 to 2019.
Ms. Brege was a Director at Avexus, Inc. and The Bay Area Bioscience Association.
She served as the Managing Director of Cervantes Life Science Partners LLC from 2015 to 2018 and was a Director at California Life Sciences Association.
Ms. Brege held the position of Treasurer & Vice President at The Cooper Cos., Inc. from 1982 to 1988 and served as the Chief Financial Officer & Senior Vice President at COR Therapeutics, Inc. from 1991 to 1999.
She was the Chief Operating & Business Officer, Executive VP at Onyx Pharmaceuticals, Inc. from 2006 to 2011 and the Chief Financial Officer & Vice President at Flextronics Corp.
from 1988 to 1991.
Ms. Brege was also a General Partner at Red Rock Capital Management, Inc. from 1999 to 2008.
Ms. Brege completed her undergraduate degree at The Ohio University in 1978.
She also holds an MBA from The University of Chicago Booth School of Business.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
PACIRA BIOSCIENCES, INC.
0.04% | 12/06/2024 | 16 552 ( 0.04% ) | 502 022 $ | 31/05/2024 |
29/05/2024 | 20 154 ( 0.01% ) | 304 325 $ | 31/05/2024 | |
05/06/2024 | 10 000 ( 0.02% ) | 240 300 $ | 31/05/2024 | |
HLS THERAPEUTICS, INC.
-.--% | 31/03/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
10/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Laura Brege
Società | Posizione | Inizio |
---|---|---|
ACADIA PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 01/05/2008 |
PACIRA BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 02/06/2011 |
HLS THERAPEUTICS INC. | Direttore/Membro del Consiglio | 21/03/2019 |
MIRUM PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 17/07/2019 |
EDGEWISE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/12/2020 |
Ohio University Foundation | Direttore/Membro del Consiglio | - |
T-Knife Therapeutics, Inc. | Direttore/Membro del Consiglio | 30/11/2021 |
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 01/06/2011 |
Council on International Educational Exchange, Inc.
Council on International Educational Exchange, Inc. Miscellaneous Commercial ServicesCommercial Services Council on International Educational Exchange, Inc. provides educational services. The firm is a non-profit study abroad and intercultural exchange organization, transforms lives and builds bridges by promoting the exchange of ideas and experiences. It offers opportunities for cultural exchange, including work exchange programs, teach abroad programs, and a worldwide portfolio of study abroad and internship programs for college and high school students. The company was founded in 1947 and is headquartered in Portland, ME. | Presidente | - |
Precedenti posizioni note di Laura Brege
Società | Posizione | Fine |
---|---|---|
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Laura Brege
The Ohio University | Undergraduate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 8 |
---|---|
THE COOPER COMPANIES, INC. | Health Technology |
DELCATH SYSTEMS, INC. | Health Technology |
DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
ACADIA PHARMACEUTICALS INC. | Health Technology |
PACIRA BIOSCIENCES, INC. | Health Technology |
HLS THERAPEUTICS INC. | Health Technology |
EDGEWISE THERAPEUTICS, INC. | Health Technology |
MIRUM PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 17 |
---|---|
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Zvents, Inc.
Zvents, Inc. Internet Software/ServicesTechnology Services Zvents, Inc. creates and operates local entertainment guides online. Its publications promote a range of local events and activities, including live music, performing arts, sporting events and community activities. The company was founded by Tyler Kovacs and Ethan Stock in 2005 and is headquartered in San Mateo, CA. | Technology Services |
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Health Technology |
Aratana Therapeutics, Inc.
Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
Avexus, Inc.
Avexus, Inc. Miscellaneous Commercial ServicesCommercial Services Avexus, Inc. provides business management services. It provides services to companies that own, operate, manufacture, supply, maintain, repair and overhaul complex assets, including product lifecycle phases. The company's solutions include reporting, analytics, workflow, logic and data integration solutions. It was founded in July, 2000 and is headquartered in San Diego, CA. | Commercial Services |
Council on International Educational Exchange, Inc.
Council on International Educational Exchange, Inc. Miscellaneous Commercial ServicesCommercial Services Council on International Educational Exchange, Inc. provides educational services. The firm is a non-profit study abroad and intercultural exchange organization, transforms lives and builds bridges by promoting the exchange of ideas and experiences. It offers opportunities for cultural exchange, including work exchange programs, teach abroad programs, and a worldwide portfolio of study abroad and internship programs for college and high school students. The company was founded in 1947 and is headquartered in Portland, ME. | Commercial Services |
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Health Technology |
The Bay Area Bioscience Association | Health Technology |
Ohio University Foundation | |
Flextronics Corp.
Flextronics Corp. Electrical ProductsProducer Manufacturing Flextronics Corp. provides fiberoptics and electronics manufacturing services. The company is located in Westford, MA. | Producer Manufacturing |
Red Rock Capital Management, Inc. | |
Cervantes Life Science Partners LLC | |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Commercial Services |
T-Knife Therapeutics, Inc. |
- Borsa valori
- Insiders
- Laura Brege